PT

Professor Triebel

Immutep Limited | Executive Director
Professor Triebel was the scientific founder of Immutep S.A. (2001) and served as the Scientific and Medical Director at Immutep from 2004. Before starting Immutep S.A., he was Professor in Immunology at Paris University. While working at Institut Gustave Roussy (IGR), a large cancer centre in Paris, he discovered the LAG-3 gene in 1990 and continued working on this research program since then, identifying the functions and medical usefulness of this molecule. He headed a research group at IGR while also being involved in the biological follow up of cancer patients treated in Phase I/II immunotherapy trials. He was Director of an INSERM Unit from 1991 to 1996.

Company and Role

Company
Title
Tenure
Since
IMM
Immutep Limited
  • Executive Director
3yrs, 10mthSep 2022

Holding

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
IMM
Immutep Limited
01/10/2511,370,825N/AN/AN/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
IMM
Immutep Limited
01/10/25
Issued
900,000$0.260$234,000Conversion of securities
IMM
Immutep Limited
01/10/25
Exercise
900,000$0.260$234,000Conversion of securities
IMM
Immutep Limited
03/04/25
Issued
1,800,000$0.260$468,000Conversion of securities
IMM
Immutep Limited
03/04/25
Exercise
1,800,000$0.260$468,000Conversion of securities
IMM
Immutep Limited
05/12/24
Issued
2,700,000$0.310$837,000Issue of securities